Clinical trial
Alimta and Gemcitabine in Non-Small Cell Lung Cancer
NCT00434135 · Southern Italy Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00434135 |
|---|---|
| Title | Alimta and Gemcitabine in Non-Small Cell Lung Cancer |
| Official title | A Phase II Randomized Trial Assessing the Combination of Gemcitabine and Pemetrexed in the First Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer |
| Acronym | ANGEL |
| Lead sponsor | Southern Italy Cooperative Oncology Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer, Stage IIIB or IV |
| Intervention type | Drug |
| Interventions | gemcitabine plus pemetrexed, paclitaxel plus gemcitabine |
| Enrollment | 180 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2008 |
| First posted | Feb 12, 2007 |
| Last update posted | Feb 5, 2009 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: